BL

Babu Lal Gupta

Active Director Director DIN 00489806
DIN 00489806 First appointment Apr 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2015
Shareholding value •••• Premium profile

About Babu Lal Gupta

Data last updated:

Babu Lal Gupta is a Director at Advance Pharmatech Drugs Private Limited (since 2015). The company operates in Healthcare. Advance Pharmatech Drugs Private Limited reported revenue of ₹94.3 Lakh (FY 2024).

DIN 00489806
Primary Designation Director
Industry Healthcare
First Appointment 06 Apr 2015
Oldest Company Age 22 yrs
Largest company Advance Pharmatech Drugs Private Limited · ₹94.3 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Apr 20152004₹94.3 Lakh (FY 2024)Active

Directorship timeline

Open interactive timeline →
Advance Pharmatech Drugs Private Limited
Premium access

Shareholding and investment profile for Babu Lal Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Babu Lal Gupta

Babu Lal Gupta currently holds 1 directorship: Advance Pharmatech Drugs Private Limited (Director, since 06 Apr 2015, revenue ₹94.3 Lakh (FY 2024)).

Babu Lal Gupta was first appointed on 06 Apr 2015 as Director at Advance Pharmatech Drugs Private Limited.

The current boards of Babu Lal Gupta's companies include Gayatri Devi Gupta (Advance Pharmatech Drugs Private Limited), Sandeep Vijay (Advance Pharmatech Drugs Private Limited), Sudeep Jain (Advance Pharmatech Drugs Private Limited), Taru Saxena (Advance Pharmatech Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available